Enter inventor name

Harry Smith

This inventor holds 35 USPTO granted patents, primarily in Allergy Treatment Compounds. Top assignees: Beecham Group Plc, Smithkline Beecham Corporation. Active years: 1976-2003.

USPTO Granted Patents = 35

% Patents Active = 100.0

Average Co-Inventor Count = 2.5

ph-index = 7

Forward Citations = 194(Granted Patents)

Location History:

Maplehurst, near Horsham, EN (1976 - 1977)
Maplehurst near Horsham, EN (1977)
Maplehurst, EN (1977)
Horsham, EN (1977)
Maplehurst, GB (1981)
Maplehurst, near Horsham, GB (1980 - 1983)
Maplehurst Nr. Horsham, GB (1980 - 1983)
Maplehurst, Nr Horsham, GB (1984)
Maplehurst Nr Horsham, GB (1984)
Maplehurst, Nr. Horsham, GB (1979 - 1988)
Epsom, GB (1998 - 2003)

Company Filing History:

Smithkline Beecham Corporation

patents

Years Active: 1976-2003

Loading Chart...

Areas of Expertise:

Benzopyranotriazoles

Coumarin Derivatives

Xanthines

Triazoles

Piperazine Derivatives

Indanediones

Pharmaceutical Compositions

Antiallergic Activity

Prophylaxis

Nitro Compounds

Carbostyril Derivatives

Heterocycles

35 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 6531600 - Treatment and compounds (2003-03-11),

2. 6180791 - Synthesis of 8-substituted xanthines (2001-01-30),

3. 5981535 - Substituted xanthines and their use in the treatment of cerebrovascular (1999-11-09),

4. 5734051 - 8-substituted xanthine derivatives and method of use thereof (1998-03-31),

5. 4769383 - Dioxonaphthotriazoles having antiallergic activity (1988-09-06),

6. 4454136 - Substituted benzopyranotriazoles and antiallergic use (1984-06-12),

7. 4427686 - Pharmacologically active benzopyranotriazole compounds (1984-01-24),

8. 4405620 - Piperazine derivatives (1983-09-20),

9. 4378360 - 6-{3-[4-(Substituted (1983-03-29),

10. 4263309 - Polycyclic triazoles used to inhibit allergic responses (1981-04-21),

11. 4263299 - Heterocyclic coumarin derivatives (1981-04-21),

12. 4248879 - Benzopyranotriazoles (1981-02-03),

13. 4223032 - Triazolo [4,5-b] quinolines and prophylaxis of allergic diseases with (1980-09-16),

14. 4211791 - Indanediones (1980-07-08),

15. 4207335 - Indan-1,3-diones (1980-06-10),

Title: The Innovative Journey of Harry Smith

Introduction

Harry Smith, residing in Maplehurst near Horsham, England, is a notable inventor with an impressive portfolio of 35 patents. His work primarily focuses on medical treatments, showcasing his commitment to advancing healthcare through innovative solutions.

Latest Patents

Among his latest achievements are groundbreaking patents related to the treatment of cerebrovascular disorders. One of his key inventions is the synthesis of 8-substituted xanthines, which provides a method for effectively treating cerebrovascular disorders and/or disorders associated with cerebral senility. This method utilizes the administration of non-toxic amounts of a specific compound, demonstrating significant potential in the medical field.

Career Highlights

Harry Smith has had a distinguished career, having worked with prominent companies such as Beecham Group Plc and SmithKline Beecham Corporation. His roles in these organizations have allowed him to contribute significantly to research and development, focusing on pharmaceutical innovations.

Collaborations

Throughout his career, Harry has collaborated with esteemed professionals like Derek R. Buckle and Barrie C. Cantello. These partnerships have enhanced the depth of his research and contributed to the success of various projects, fostering a collaborative environment that drives innovation.

Conclusion

In conclusion, Harry Smith stands as a remarkable figure in the realm of innovation, with a strong focus on medical advancements through his numerous patents. His contributions to the field reflect a dedication to improving health outcomes, establishing him as a significant inventor in his area of expertise.

Profile summary based on public USPTO records.

Please report any incorrect information to [email protected]